These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16913403)

  • 1. [Development of new software (Ver. 2.0) based on the Bayesian estimation utilized in the therapeutic drug monitoring of teicoplanin, a glycopeptide antibiotic].
    Niwa T; Tabata K; Kimura J; Kamada M; Noda Y; Takagi A
    Jpn J Antibiot; 2006 Jun; 59(3):165-76. PubMed ID: 16913403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of software for data analysis by therapeutic drug monitoring of teicoplanin, a glycopeptide antibiotic].
    Niwa T; Tokuma Y; Ito T; Kimura J; Tabata K; Takagi A
    Jpn J Antibiot; 2004 Aug; 57(4):413-9. PubMed ID: 15535042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring based on early measurements of serum teicoplanin levels in Japanese patients.
    Oda K; Kasada T; Yoshikawa M; Tanoue M; Yamashita T; Takeshita Y
    Ther Drug Monit; 2014 Jun; 36(3):401-5. PubMed ID: 24270046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian approach to drug disposition evaluation: application to teicoplanin.
    Ferrante L; Bompadre S; Cingolani ML; Leone L
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):410-4. PubMed ID: 7582399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teicoplanin population pharmacokinetic analysis in hospitalized patients.
    Soy D; López E; Ribas J
    Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.
    Ramos-Martín V; Neely MN; Padmore K; Peak M; Beresford MW; Turner MA; Paulus S; López-Herce J; Hope WW
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inter-individual and intra-individual pharmacokinetic variability during teicoplanin therapy in geriatric patients].
    Uhart M; Leroy B; Michaud A; Maire P; Bourguignon L
    Med Mal Infect; 2013 Jul; 43(7):295-8. PubMed ID: 23906420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacokinetics of individual teicoplanin components in patients.
    Hanada K; Ikari S; Koukaki Y; Utena A; Kimura T; Hamano K; Ariki H; Masuhara K; Ogata H
    Biol Pharm Bull; 2007 May; 30(5):952-4. PubMed ID: 17473441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
    Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
    Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.
    Lamont E; Seaton RA; Macpherson M; Semple L; Bell E; Thomson AH
    J Antimicrob Chemother; 2009 Jul; 64(1):181-7. PubMed ID: 19411678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study.
    Roberts JA; Stove V; De Waele JJ; Sipinkoski B; McWhinney B; Ungerer JP; Akova M; Bassetti M; Dimopoulos G; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J;
    Int J Antimicrob Agents; 2014 May; 43(5):423-30. PubMed ID: 24630304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing population pharmacokinetic parameters for high-dose methotrexate therapy: implication of correlations among developed parameters for individual parameter estimation using the Bayesian least-squares method.
    Watanabe M; Fukuoka N; Takeuchi T; Yamaguchi K; Motoki T; Tanaka H; Kosaka S; Houchi H
    Biol Pharm Bull; 2014; 37(6):916-21. PubMed ID: 24882404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of teicoplanin in patients with endocarditis.
    Yu DK; Nordbrock E; Hutcheson SJ; Lewis EW; Sullivan W; Bhargava VO; Weir SJ
    J Pharmacokinet Biopharm; 1995 Feb; 23(1):25-39. PubMed ID: 8576842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation and evaluation of a stochastic control strategy for individualizing teicoplanin dosage regimen.
    Tod M; Alet P; Lortholary O; Petitjean O
    J Pharmacokinet Biopharm; 1997 Dec; 25(6):695-712. PubMed ID: 9697078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis.
    Brink AJ; Richards GA; Lautenbach EE; Rapeport N; Schillack V; van Niekerk L; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jun; 45(6):647-51. PubMed ID: 25819167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.
    Pea F; Brollo L; Viale P; Pavan F; Furlanut M
    J Antimicrob Chemother; 2003 Apr; 51(4):971-5. PubMed ID: 12654757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. About the equivalence between different batches of a glycopeptide drug.
    Boix-Montañes A; Garcia-Arieta A
    Pharm Dev Technol; 2016 Aug; 21(5):642-5. PubMed ID: 25886080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of serum vancomycin concentrations using one-, two- and three-compartment models with implemented population pharmacokinetic parameters and with the Bayesian method.
    Wu G; Furlanut M
    J Pharm Pharmacol; 1998 Aug; 50(8):851-6. PubMed ID: 9751448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model-informed precision dosing of teicoplanin for the rapid achievement of the target area under the concentration-time curve: A simulation study.
    Oda K; Yamada T; Matsumoto K; Hanai Y; Ueda T; Samura M; Shigemi A; Jono H; Saito H; Kimura T
    Clin Transl Sci; 2023 Apr; 16(4):704-713. PubMed ID: 36748688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age- and gender-related differences in teicoplanin levels in paediatric patients.
    Strenger V; Hofer N; Rödl S; Hönigl M; Raggam R; Seidel MG; Dornbusch HJ; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urlesberger B; Urban C
    J Antimicrob Chemother; 2013 Oct; 68(10):2318-23. PubMed ID: 23702837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.